Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Long-term immunosuppressant tablet. | Immunosuppressant for transplants and lupus kidney disease. |
| Body system | Joints & Immunity | Joints & Immunity |
| Drug class | Antiproliferative immunosuppressants | Antiproliferative immunosuppressants |
| Supply | Prescription onlyWHO essential medicine | Prescription only |
| Main uses | Crohn's disease and ulcerative colitis, Autoimmune hepatitis, Lupus and vasculitis, Transplant rejection prevention, Myasthenia gravis | Kidney, liver and heart transplants, Lupus nephritis, Vasculitis and other autoimmune diseases |
| How it works | Slows down overactive immune cells. | Stops immune cells multiplying. |
| Starts working | 2–3 months | — |
| Half-life | — | About 18 hours |
| Typical adult dose | 1–2.5 mg/kg a day, depending on TPMT activity. | Commonly 1–1.5 g twice a day (mofetil). |
| Forms | Tablet, Injection | Tablet, Capsule, Oral suspension, IV infusion, Gastro-resistant tablet |
| Common side effects | Nausea, Flu-like symptoms early, Tiredness | Diarrhoea, Nausea, Low white cells |
| Serious side effects | Bone marrow suppression, Pancreatitis, Liver injury, Skin cancer and lymphoma | Serious infections, Birth defects and miscarriage, Lymphoma and skin cancer, PML (rare brain infection) |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Use with cautionOften continued in IBD and lupus when needed. | Usually avoidedContraindicated — high rate of birth defects. |
| Breastfeeding | — | — |
| In use since | 1968 | 1995 |
| Brand names | United States: Imuran, AzasanUnited Kingdom: ImuranIndia: Azoran, Azimune | United States: CellCept, MyforticUnited Kingdom: CellCept, Myfenax, MyforticIndia: Mycept, Cellmune |
| Legal status | — | — |
| ATC code | L04AX01 | L04AA06 |
Taken together
- ModerateAzathioprine + Mycophenolate: Added bone marrow suppression
Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.